EF 4 (Balversa 4 mg)
Generic Name: erdafitinib
Pill with imprint EF 4 is Orange, Round and has been identified as Balversa 4 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Balversa is used in the treatment of urothelial carcinoma; bladder cancer and belongs to the drug class multikinase inhibitors. Balversa 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EF 4
Related images for "EF 4"
More about Balversa (erdafitinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.